Monday, June 1, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Contrarian

Normalizing Healthcare Policy Polarizations

Daily Remedy by Daily Remedy
January 2, 2022
in Contrarian
0
Normalizing Healthcare Policy Polarizations

The physician who first submitted a patent which paved the way for mRNA vaccines is not a celebrated American hero. He is not a fixture on mainstream media outlets. And he has been banned from multiple social media outlets on many occasions.

His name is Dr. Robert Malone. These days, his name is associated more with fringe than celebrated, which is curious given his decades of illustrious success in vaccine development. In the 1980’s and 1990’s, while at the Salk Institute for Biological Studies, he pioneered research that led to mRNA vaccines. He was on the scientific advisory board of EpiVax, a vaccine technology company, and has served as an executive to multiple pharmaceutical companies.

By any measure he should be considered a luminary in the field of vaccine development and enshrined in American medical history. But he is not, quite the opposite, and to understand why we should look no further than at the powers that be at the National Institutes of Health (NIH).

Two names in particular, Dr. Anthony Fauci and Dr. Francis Collins, are largely responsible for the sordid state in which Dr. Malone and other once prominent physicians find themselves. In recently uncovered email exchanges, the two are found to have orchestrated – in their words – quick and devastating published take downs of healthcare policy proposals, and the physicians who support them, that contradict what the two believe.

In any other instance, the jury of public opinion would have mercilessly eviscerated these two healthcare policy leaders. But both men are luminaries in their own right, with impeccable accomplishments over decades of public health service that easily rival Dr. Malone’s successes.

This makes the matter all the more confusing. Science thrives on debate and scientific research depends on challenging conventionally held notions. But during the pandemic, public health policy became deeply polarized. Instead of traditional scientific debate, we had policy experts hastily publishing poorly written clinical studies and jumping onto the first media outlet they could find with a friendly microphone – touting and reiterating their policy views until what they believed was all that anybody should believe and those who thought otherwise should not be taken seriously.

In such an environment, the email exchange between Dr. Fauci and Dr. Collins becomes par for the course. Truly, at this stage of the pandemic, the revelations from the email exchange confirm what we secretly assumed to be true. And few were surprised when the emails came out.

In a few short months we normalized polarizing behavior in public health. There is no room for common ground any more. To discuss public health these days you must either be a libertarian or a communist.

But this very metaphor alludes to the source of the problem. When anything is polarized, it becomes distorted. Public health policy and healthcare policy in general should never be understood in political or economic terms. Yet this is exactly how we discuss them during the pandemic.

Sure there is an overlap among medicine, politics, and economics. We cannot discuss healthcare without including the cost of care these days. But they remain distinct, even if the distinction may feel blurry at times.

In politics and economics, dissent and conflict are forms of gambit – they are how you advance in these fields. But in public health, solutions are found in compromise and the field advances by taking into account all expert opinions. Dissent and conflict must give way to compromise in matters of public health policy. When it does not, the public suffers.

Overdoses and suicides peaked during the early months of the pandemic, when lockdowns were at their most severe. In response, many rebelled against the restrictions, swaying to the opposite extreme. Only later did we realize the ideal course of action was a compromise between the two extremes.

This is the nature of public health. We take differing views and settle for a compromised approach. But when we polarize public health, we distort it into something different. It is no longer about compromise, but about dissent and conflict – and eventually power and control.

And when we normalize the polarization of healthcare policies, we find policy leaders who are no longer concerned about healthcare.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Observations From the Rx & Illicit Drug Summit

    Observations From the Rx & Illicit Drug Summit

    0 shares
    Share 0 Tweet 0
  • When Hospitals Can Be Liable for Abusive Providers

    0 shares
    Share 0 Tweet 0
  • Employers Don’t Really Care About Your Mental Health

    0 shares
    Share 0 Tweet 0
  • Retatrutide: The Weight Loss Drug Everyone Wants—But Can’t Officially Get

    1 shares
    Share 0 Tweet 0
  • Case Analysis of Dr. Ball

    1 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy